1. Home
  2. BMRA vs ICU Comparison

BMRA vs ICU Comparison

Compare BMRA & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biomerica Inc.

BMRA

Biomerica Inc.

HOLD

Current Price

$2.15

Market Cap

7.7M

Sector

Health Care

ML Signal

HOLD

Logo SeaStar Medical Holding Corporation

ICU

SeaStar Medical Holding Corporation

HOLD

Current Price

$2.26

Market Cap

9.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMRA
ICU
Founded
1971
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
9.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BMRA
ICU
Price
$2.15
$2.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.6K
119.4K
Earning Date
01-14-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,457,000.00
$881,000.00
Revenue This Year
N/A
$1,043.70
Revenue Next Year
N/A
$54.99
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1195.59
52 Week Low
$2.11
$2.20
52 Week High
$8.80
$25.70

Technical Indicators

Market Signals
Indicator
BMRA
ICU
Relative Strength Index (RSI) 37.93 56.17
Support Level $2.14 $2.31
Resistance Level $2.33 $2.74
Average True Range (ATR) 0.10 0.19
MACD -0.02 -0.09
Stochastic Oscillator 18.09 21.57

Price Performance

Historical Comparison
BMRA
ICU

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: